Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.
Company profile
Ticker
PETX
Exchange
Website
CEO
Craig A. Tooman
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
383826477
PETX stock data
Latest filings (excl ownership)
15-12B
Securities registration termination
29 Jul 19
EFFECT
Notice of effectiveness
22 Jul 19
EFFECT
Notice of effectiveness
22 Jul 19
25-NSE
Exchange delisting
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Jul 19
Latest ownership filings
SC 13G
Aratana Therapeutics, Inc.
29 Jul 19
4
KEVIN KOTLER
22 Jul 19
SC 13G/A
Aratana Therapeutics, Inc.
22 Jul 19
4
WENDY L YARNO
18 Jul 19
4
Vort John Vander
18 Jul 19
4
CRAIG A TOOMAN
18 Jul 19
4
ROBERT P ROCHE JR
18 Jul 19
4
LOWELL W ROBINSON
18 Jul 19
4
CHRISTOPHER T READY
18 Jul 19
4
MERILEE RAINES
18 Jul 19
Institutional ownership, Q3 2021
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|